Statin and aspirin use among hispanic and latino adults at high cardiovascular risk: Findings from the hispanic community health study/study of latinos

Journal of the American Heart Association

Volumn 5, Issue 4, 2016, Pages

  Qato, Dima M ^a   Lee, Todd A ^a   Durazo Arvizu, Ramon ^b,c   Wu, Donghong ^c   Wilder, Jocelyn ^a   Reina, Samantha A ^d   Cai, Jianwen ^e   Gonzalez, Franklyn ^e   Talavera, Gregory A ^f   Ostfeld, Robert J ^g   Daviglus, Martha L ^c  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

^c UNIVERSITY OF ILLINOIS   (United States)

^d University of Miami   (United States)

^e University of North Carolina at Chapel Hill   (United States)

^f SAN DIEGO STATE UNIVERSITY   (United States)

^g MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

Cardiovascular risk; Disparities; Hispanic Latino; Statins

Indexed keywords

ACETYLSALICYLIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CENTRAL AMERICAN; COHORT ANALYSIS; CONTROLLED STUDY; CUBAN; DOMINICAN (DOMINICA); FEMALE; HEALTH INSURANCE; HISPANIC; HUMAN; INFORMED CONSENT; MALE; MEXICAN; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUERTO RICAN; RISK FACTOR; SOUTH AMERICAN; ADOLESCENT; CARDIOVASCULAR DISEASES; CENTRAL AMERICA; CLINICAL TRIAL; CUBA; DOMINICAN REPUBLIC; ETHNOLOGY; MEXICAN AMERICAN; MIDDLE AGED; MULTICENTER STUDY; PUERTO RICO; SOUTH AMERICA; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ASPIRIN; CARDIOVASCULAR DISEASES; CENTRAL AMERICA; CUBA; DOMINICAN REPUBLIC; FEMALE; HISPANIC AMERICANS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MEXICAN AMERICANS; MIDDLE AGED; PREVALENCE; PUERTO RICO; RISK FACTORS; SOUTH AMERICA; YOUNG ADULT;

EID: 84995614763     PISSN: None     EISSN: 20479980     Source Type: Journal    
DOI: 10.1161/JAHA.115.002905     Document Type: Article

References (12)

1. Qato DM, Alexander GC, Conti RM, Johnson M, Schumm P, Lindau ST. Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA. 2008;300:2867- 2878.
2. Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith SC Jr, Watson K, Wilson PW, Eddleman KM, Jarrett NM, LaBresh K, Nevo L, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Smith SC Jr, Tomaselli GF. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:S1-S45.
3. Stone NJ, Robinson JG, Lichtenstein AH, Goff DC Jr, Lloyd-Jones DM, Smith SC Jr, Blum C, Schwartz JS. Treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: synopsis of the 2013 American College of Cardiology/American Heart Association cholesterol guideline. Ann Intern Med. 2014;160:339-343.
4. Parekh AK, Galloway JM, Hong Y, Wright JS. Aspirin in the secondary prevention of cardiovascular disease. N Engl J Med. 2013;368:204-205.
5. Xie M, Shan Z, Zhang Y, Chen S, Yang W, Bao W, Rong Y, Yu X, Hu FB, Liu L. Aspirin for primary prevention of cardiovascular events: meta-analysis of randomized controlled trials and subgroup analysis by sex and diabetes status. PLoS One. 2014;9:e90286.
6. Daviglus ML, Talavera GA, Aviles-Santa ML, Allison M, Cai J, Criqui MH, Gellman M, Giachello AL, Gouskova N, Kaplan RC, LaVange L, Penedo F, Perreira K, Pirzada A, Schneiderman N, Wassertheil-Smoller S, Sorlie PD, Stamler J. Prevalence of major cardiovascular risk factors and cardiovascular diseases among Hispanic/Latino individuals of diverse backgrounds in the United States. JAMA. 2012;308:1775-1784.
7. Qato DM, Lindau ST, Conti RM, Schumm LP, Alexander GC. Racial and Ethnic disparities in cardiovascular medication use among older adults in the United States. Pharmacoepidemiol Drug Saf. 2010;19:834-842.
8. Mann D, Reynolds K, Smith D, Muntner P. Trends in statin use and low-density lipoprotein cholesterol levels among US adults: impact of the 2001 National Cholesterol Education Program guidelines. Ann Pharmacother. 2008;42:1208- 1215.
9. Sorlie PD, Aviles-Santa LM, Wassertheil-Smoller S, Kaplan RC, Daviglus ML, Giachello AL, Schneiderman N, Raij L, Talavera G, Allison M, Lavange L, Chambless LE, Heiss G. Design and implementation of the Hispanic Community Health Study/Study of Latinos. Ann Epidemiol. 2010;20:629-641.
10. Expert Panel on Detection E, Treatment of High Blood Cholesterol in A. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001;285:2486- 2497.
11. Sommers BD, Musco T, Finegold K, Gunja MZ, Burke A, McDowell AM. Health reform and changes in health insurance coverage in 2014. N Engl J Med. 2014;371:867-874.
12. Doty MM, Rasmussen PW, Collins SR. Catching up: Latino health coverage gains and challenges under the Affordable Care Act: results from the Commonwealth Fund Affordable Care Act Tracking Survey. Issue Brief (Commonw Fund). 2014;26:1-15.